Replies to post #1582 on Arch Therapeutics Inc (ARTH)

[Amatuer17]

The funding is the big concern for me as well

As the trial has started and the trial is comparatively short compared to most of the other drugs - I hope mgmt uses the upcoming results to get a partner as dilution strategy rsther than going to private investors or secondary market - a partner will give more credibility and push the price up.

They may not get as much multiple but it will avoid the survival mode of funding